Intervention Protocol

You have free access to this content

Glycopyrronium bromide for chronic obstructive pulmonary disease

  1. Joseph P Burke1,*,
  2. Jacques G Eastment1,
  3. Rayleen V Bowman1,2,
  4. Kwun M Fong1,2,
  5. Ian A Yang1,2

Editorial Group: Cochrane Airways Group

Published Online: 31 OCT 2013

DOI: 10.1002/14651858.CD010798


How to Cite

Burke JP, Eastment JG, Bowman RV, Fong KM, Yang IA. Glycopyrronium bromide for chronic obstructive pulmonary disease (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD010798. DOI: 10.1002/14651858.CD010798.

Author Information

  1. 1

    The University of Queensland, School of Medicine, Brisbane, Australia

  2. 2

    The Prince Charles Hospital, Thoracic Medicine Program, Brisbane, Queensland, Australia

*Joseph P Burke, School of Medicine, The University of Queensland, Brisbane, Australia. joseph.burke@uqconnect.edu.au.

Publication History

  1. Publication Status: New
  2. Published Online: 31 OCT 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To critically appraise the efficacy and safety of glycopyrronium bromide, in terms of objective and subjective measures, in patients with COPD.